Epidemiology of lactic acidosis in type 2 diabetes patients with metformin in Japan

To estimate the incidence of lactic acidosis (LA) and role of metformin in Japanese patients with type 2 diabetes mellitus (T2DM) treated with anti‐diabetes drugs.

• Publication year

  2016

• Venue

  Pharmacoepidemiology and Drug Safety

• Publication date

  2016-05-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/pds.4030PMID 27221971PMCID 5089598
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidemiology of lactic acidosis in type 2 diabetes patients with metformin in Japan

  2016cited by this paper
• Midwife-led continuity models versus other models of care for childbearing women.

  2016cited by this paper
• Left truncation results in substantial bias of the relation between time-dependent exposures and adverse events.

  2015cited by this paper
• Metformin in patients with type 2 diabetes and kidney disease: a systematic review.

  2014cited by this paper
• Optimal therapy of type 2 diabetes: a controversial challenge

  2014cited by this paper
• The Role of Metformin in Metformin-Associated Lactic Acidosis (MALA): Case Series and Formulation of a Model of Pathogenesis

  2013cited by this paper
• Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  2013cited by this paper
• Metformin therapy and kidney disease: a review of guidelines and proposals for metformin withdrawal around the world

  2013cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

  2012cited by this paper
• PROPENSITY SCORE ANALYSIS AND ASSESSMENT OF PROPENSITY SCORE APPROACHES USING SAS ® PROCEDURES

  2012cited by this paper
• Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes.

  2012cited by this paper
• Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes

  2012cited by this paper
• Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements

  2011cited by this paper
• Usefulness of a large automated health records database in pharmacoepidemiology

  2011cited by this paper
• Metformin use and mortality among patients with diabetes and atherothrombosis.

  2010cited by this paper
• Fasting Plasma Lactate Concentrations in Ambulatory Elderly Patients With Type 2 Diabetes Receiving Metformin Therapy: A Retrospective Cross‐sectional Study

  2010cited by this paper
• Long-Term Compliance of Salt Restriction and Blood Pressure Control Status in Hypertensive Outpatients

  2010cited by this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

  2010cited by this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

  2010cited by this paper
• Treatment of type 2 diabetes in chronic kidney disease: meekly follow the herd or call to arms?

  2009cited by this paper
• Metformin in renal failure--weigh the evidence.

  2009cited by this paper
• Factors Predisposing an Abstract To Be Accepted for Oral Presentation

  2008cited by this paper
• Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated?

  2007cited by this paper
• Metformin-associated lactic acidosis in a patient with liver disease.

  2003cited by this paper
• Research evidence and the individual patient.

  2003cited by this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

  2003cited by this paper
• Use of base in the treatment of severe acidemic states.

  2001cited by this paper
• Sodium bicarbonate for the treatment of lactic acidosis.

  2000cited by this paper
• Incidence of lactic acidosis in metformin users.

  1999cited by this paper
• First 20 months' experience with use of metformin for type 2 diabetes in a large health maintenance organization.

  1999cited by this paper
• Hepatic pyruvate dehydrogenase activity in humans: effect of cirrhosis, transplantation, and dichloroacetate.

  1998cited by this paper
• Hepatic pyruvate dehydrogenase activity in humans: effect of cirrhosis, transplantation, and dichloroacetate.

  1998cited by this paper
• Is metformin safe enough for ageing type 2 diabetic patients?

  1996cited by this paper
• Biguanides and NIDDM

  1992cited by this paper
• Modeling and variable selection in epidemiologic analysis.

  1989cited by this paper

• Acidosis láctica inducida por metformina en paciente con enfermedad renal crónica

  2025cites this paper
• Prescription trend and lactic acidosis in patients prescribed metformin before and after the revision of package insert for allowing metformin administration to patients with moderately decreased kidney function based on real-world data from MID-NET® in Japan

  2024cites this paper
• Metformin exposure and the incidence of lactic acidosis in critically ill patients with T2DM: A retrospective cohort study

  2024cites this paper
• Risk of Lactic Acidosis in Hospitalized Diabetic Patients Prescribed Biguanides in Japan: A Retrospective Total-Population Cohort Study

  2023cites this paper
• Reversible acute blindness in suspected metformin-associated lactic acidosis: a case report

  2023cites this paper
• Changes in the Penetration Rate of Biosimilar Infliximab Within Japan Using a Japanese Claims Database

  2021cites this paper
• A Claims Database Analysis of Dose-Dependency of Metformin and Incidence of Lactic Acidosis in Japanese Patients with Type 2 Diabetes

  2021influential citation
• CEOR_A_293698 145..153

  2021cites this paper
• Effects of Increasing Metformin Dose vs Adding/Switching to Dipeptidyl Peptidase-4 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes

  2021cites this paper
• Risk factors for acute decompensated heart failure in type 2 diabetes patients acute heart

  2020cites this paper
• Risk factors for acute decompensated heart failure in type 2 diabetes patients

  2020cites this paper
• Reversible Acute Blindness in Suspected Metformin-Associated Lactic Acidosis.

  2019cites this paper
• Co-insurance and health care utilization in Japanese patients with rheumatoid arthritis: a discontinuity regression approach

  2019cites this paper
• Incidence, factors related to presentation, course and mortality of metformin-associated lactic acidosis in the healthcare area of a tertiary hospital

  2019cites this paper
• Incidence, factors related to presentation, course and mortality of metformin-associated lactic acidosis in the healthcare area of a tertiary hospital.

  2019cites this paper
• Lactic acidosis associated with metformin in patients with moderate to severe chronic kidney disease: study protocol for a multicenter population-based case-control study using health databases

  2019cites this paper
• Metformin v/s glibenclamide : for intial therapy of type 2 diabetes mellitus in a tertiary care hospital, a comparative study, for efficacy and tolerability

  2019cites this paper
• Type 2 diabetes treatment and progression of chronic kidney disease in Italian family practice

  2018cites this paper
• Pharmacotherapy of type 2 diabetes in patients with chronic liver disease: focus on nonalcoholic fatty liver disease

  2018cites this paper
• Persistence with Biological Disease-modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs

  2018cites this paper
• Successful treatment of metformin-associated lactic acidosis in a hemodialysis patient

  2018cites this paper
• Does metformin exposure before ICU stay have any impact on patients’ outcome? A retrospective cohort study of diabetic patients

  2017cites this paper
• リアルワールドデータ (RWD) の活用と課題—製薬業界での取り組み

  2017cites this paper
• Usage of metformin in patients with type 2 diabetes mellitus

  2016cites this paper
• Epidemiology of lactic acidosis in type 2 diabetes patients with metformin in Japan

  2016cites this paper
• Piracetam Facilitates the Anti-Amnesic but not Anti-Diabetic Activity of Metformin in Experimentally Induced Type-2 Diabetic Encephalopathic Rats

  2016cites this paper